"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
A study looking at clarithromycin for weight loss in people with lung cancer
More about this trial
Weight loss (cachexia) is common in people with lung cancer. It involves loss of muscle which can reduce your ability to get around and to look after yourself. One of your body’s responses to cancer is
Clarithromycin is, an antibiotic used to fight infection. We know from research that clarithromycin can reduce the inflammation caused by non small cell lung cancer. This can lead to an increase of weight, fewer admissions into hospital and an increase in how long people lived. But these were small studies and a larger study needs to be done to see if it gets the same results. Before doing this, researchers need to make sure that it would be possible to do.
In this study some people were due to have clarithromycin and the others a dummy drug (
Summary of results
This study closed early as the researchers were unable to find enough suitable people to take part.
How to join a clinical trial
Dr Andrew Wilcock
NIHR Clinical Research Network: Cancer
Roy Castle Lung Cancer Foundation
University of Nottingham